RTAC

Renatus Tactical Acquisition Corp I - 10-Q Summary (Q1 2026)

Business Context and Reporting Period

Company: Renatus Tactical Acquisition Corp I (RTAC), a Cayman Islands exempted company and blank check SPAC.

Reporting Period: Three months ended March 31, 2026.

Status: The Company is in the pre-business combination phase. It consummated its Initial Public Offering (IPO) on May 16, 2025, raising $241.5 million. As of the reporting date, the Company has not commenced operations and is actively searching for a target business. The Company is classified as a shell company, a smaller reporting company, and an emerging growth company.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue and Income: The Company reported net income of $1.81 million, driven entirely by interest income earned on the Trust Account ($2.09 million). This is a significant change from Q1 2025, where the Company had no operations or income as the IPO had not yet closed.
• Trust Account Growth: Cash held in the Trust Account increased from $248.2 million (Dec 31, 2025) to $250.3 million (Mar 31, 2026) due to accrued interest.
• Debt Issuance: The Company issued a new convertible promissory note of $80,000 in January 2026, bringing total convertible notes outstanding to $330,000 (up from $250,000 at year-end 2025).
• Operating Cash Flow: Net cash used in operating activities was $77,594, primarily due to operating expenses offset by changes in working capital.

Outlook, Risks, and Management Commentary

• Going Concern: Management has raised substantial doubt about the Company's ability to continue as a going concern. Operating cash outside the Trust Account is only $10,977, which is insufficient to fund operations for the next 12 months. The Company relies on additional financing (e.g., working capital loans from the Sponsor or affiliates) to continue its search for a business combination.
• Combination Deadline: The Company must complete a business combination within 24 months of the IPO (May 2027), extendable by up to 30 months in total. Failure to do so will result in liquidation and redemption of public shares.
• Deferred Fees: A deferred underwriting fee of $8,452,500 is payable only upon the successful completion of a business combination.
• Risk Factors: Risks include the inability to find a suitable target, market volatility, geopolitical conflicts (Russia-Ukraine, Middle East), and the potential for the Sponsor to be unable to satisfy indemnification obligations if third-party claims reduce Trust Account funds.
• Subsequent Events: On April 24, 2026, the Company issued two additional convertible promissory notes totaling $300,000 at an 8% interest rate.

Investor Verification Checklist

• Liquidity Runway: Verify the Company's ability to secure additional working capital loans from the Sponsor or affiliates to cover operating expenses until a business combination is consummated.
• Trust Account Interest: Monitor the interest rate environment and its impact on the redemption value per share (currently approx. $10.36).
• Convertible Note Terms: Review the conversion terms of the $330,000 in outstanding notes (conversion price of $5.00 per unit) and the subsequent $300,000 notes issued in April 2026 (conversion price of $3.00 per unit), as these represent significant potential dilution.
• Extension Options: Confirm if the Company intends to exercise its option to extend the combination period beyond the initial 24 months, which may require shareholder approval or additional funding.
• Redemption Rights: Understand that public shareholders have the right to redeem shares for a pro-rata portion of the Trust Account, which could impact the capital available for a transaction.